• candyman337@lemmy.world
      link
      fedilink
      English
      arrow-up
      17
      ·
      edit-2
      2 days ago

      Literally the rhetoric that the Nazis used as an excuse to experiment on Jews in concentration camps

      • bryndos@fedia.io
        link
        fedilink
        arrow-up
        3
        arrow-down
        10
        ·
        2 days ago

        I don’t know much about nazis but I thought an important part of their rhetoric was to draw distinctions between types of human.

        So they’d not see “10bn humans”, they’d see maybe 100m aryan and 9.9bn “untermensch”; the latter being equivalent to rats available to be experimented on.

        I just find rats to be much more preferable, pleasant and considerate creatures than humans. I see humans as a single tier of unterratten; totally different hierarchcy.

        • lime!@feddit.nu
          link
          fedilink
          English
          arrow-up
          12
          ·
          2 days ago

          so how do you choose which humans to experiment on? bearing in mind that any sort of incentive will automatically select for a particular subset, and randomness will “obviously” need to exclude a particular subset

          • bryndos@fedia.io
            link
            fedilink
            arrow-up
            1
            arrow-down
            1
            ·
            2 days ago

            A researcher should offer a sufficient compensation package to get enough volunteers after explaining the risks. They should get independent medical advice too.

            They can still randomize within the volunteers with treatment / placebo, and maybe use quotas, but they’d just have to extend their trial period until they’d achieved a measurably representative treatment and control group and enough volunteers to test the hypothesis to the required level.

            This type of non-random sampling may very well have to be done anyway, for example if they needed the power to test efficacy and safety in all the potential dug interactions or co-morbidity scenarios. Not to mention any diagnosis requirement will also screen the sample which could be influenced by health care system resources and policies, not necessarily pure morbidity. So I think they can deal with non-random sampling in med research perfectly well.